Literature DB >> 15031620

A framework for controlling false discovery rates and minimizing the amount of genotyping in the search for disease mutations.

Edwin J C G van den Oord1, Patrick F Sullivan.   

Abstract

OBJECTIVES: To develop a method for designing studies to find disease mutations that can achieve a set of goals with respect to proportions of false and true discoveries with the minimum amount of genotyping.
METHODS: Derivation of an analytical framework supplemented with simulation techniques. The approach is illustrated for a fine mapping study and a whole-genome linkage disequilibrium scan.
RESULTS: The use of multiple stages where earlier stages are characterized by very high false discovery rates (FDR) followed by an abrupt change to the required FDR in the final stage results in a 50-75% reduction in genotyping. The proportion of true discoveries is a much more important determinant of the genotyping burden than the FDR. Neither sample size nor controlling the false discoveries will present major problems in whole-genome LD scans but the amount of genotyping will be extremely large even if the study is completely designed to minimize genotyping.
CONCLUSIONS: The proposed statistical framework presents a simple and flexible approach to determine the design parameters (e.g. sample size, p values at which tests need to be performed at each stage) that minimize the genotyping burden given a set of goals for the percentage of true and false discoveries. Copyright 2003 S. Karger AG, Basel

Mesh:

Year:  2003        PMID: 15031620     DOI: 10.1159/000076393

Source DB:  PubMed          Journal:  Hum Hered        ISSN: 0001-5652            Impact factor:   0.444


  14 in total

Review 1.  Recent developments in genomewide association scans: a workshop summary and review.

Authors:  Duncan C Thomas; Robert W Haile; David Duggan
Journal:  Am J Hum Genet       Date:  2005-08-01       Impact factor: 11.025

2.  Association of two DRD2 gene polymorphisms with acute and tardive antipsychotic-induced movement disorders in young Caucasian patients.

Authors:  Jeroen P Koning; Jelle Vehof; Huibert Burger; Bob Wilffert; Asmar Al Hadithy; Behrooz Alizadeh; Peter N van Harten; Harold Snieder
Journal:  Psychopharmacology (Berl)       Date:  2011-07-13       Impact factor: 4.530

3.  A grid-search algorithm for optimal allocation of sample size in two-stage association studies.

Authors:  S H Wen; C K Hsiao
Journal:  J Hum Genet       Date:  2007-06-30       Impact factor: 3.172

4.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

5.  Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.

Authors:  D E Adkins; K Aberg; J L McClay; J Bukszár; Z Zhao; P Jia; T S Stroup; D Perkins; J P McEvoy; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2010-03-02       Impact factor: 15.992

6.  Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.

Authors:  J L McClay; D E Adkins; K Aberg; S Stroup; D O Perkins; V I Vladimirov; J A Lieberman; P F Sullivan; E J C G van den Oord
Journal:  Mol Psychiatry       Date:  2009-09-01       Impact factor: 15.992

7.  Catechol-O-methyltransferase contributes to genetic susceptibility shared among anxiety spectrum phenotypes.

Authors:  John M Hettema; Seon-Sook An; Jozsef Bukszar; Edwin J C G van den Oord; Michael C Neale; Kenneth S Kendler; Xiangning Chen
Journal:  Biol Psychiatry       Date:  2008-04-23       Impact factor: 13.382

8.  Association study of SNAP25 and schizophrenia in Irish family and case-control samples.

Authors:  A H Fanous; Z Zhao; E J C G van den Oord; B S Maher; D L Thiselton; S E Bergen; B Wormley; T Bigdeli; R L Amdur; F A O'Neill; D Walsh; K S Kendler; B P Riley
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

9.  Association between genes of Disrupted in schizophrenia 1 (DISC1) interactors and schizophrenia supports the role of the DISC1 pathway in the etiology of major mental illnesses.

Authors:  Liisa Tomppo; William Hennah; Päivi Lahermo; Anu Loukola; Annamari Tuulio-Henriksson; Jaana Suvisaari; Timo Partonen; Jesper Ekelund; Jouko Lönnqvist; Leena Peltonen
Journal:  Biol Psychiatry       Date:  2009-02-28       Impact factor: 13.382

10.  Genome-wide association for major depressive disorder: a possible role for the presynaptic protein piccolo.

Authors:  P F Sullivan; E J C de Geus; G Willemsen; M R James; J H Smit; T Zandbelt; V Arolt; B T Baune; D Blackwood; S Cichon; W L Coventry; K Domschke; A Farmer; M Fava; S D Gordon; Q He; A C Heath; P Heutink; F Holsboer; W J Hoogendijk; J J Hottenga; Y Hu; M Kohli; D Lin; S Lucae; D J Macintyre; W Maier; K A McGhee; P McGuffin; G W Montgomery; W J Muir; W A Nolen; M M Nöthen; R H Perlis; K Pirlo; D Posthuma; M Rietschel; P Rizzu; A Schosser; A B Smit; J W Smoller; J-Y Tzeng; R van Dyck; M Verhage; F G Zitman; N G Martin; N R Wray; D I Boomsma; B W J H Penninx
Journal:  Mol Psychiatry       Date:  2008-12-09       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.